COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
Trial ID or NCT#
NCT00790335
Status
Purpose
The purpose of this study is to determine if the use of adjunctive Pharmacomechanical Catheter Directed Thrombolysis, which includes the intrathrombus administration of rt-PA--Activase (Alteplase),can prevent the post-thrombotic syndrome(PTS)in patients with symptomatic proximal deep vein thrombosis(DVT)as compared with optimal standard DVT therapy alone.
Official Title
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Eligibility Criteria
Ages Eligible for Study: 16 Years to 75 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Donald Schreiber
Emergency medicine doctor
Associate Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Daniel Sze, MD, PhD
Interventional radiologist
Professor of Radiology (Interventional Radiology) at the Stanford University Medical Center
Nishita Kothary, MD
Interventional radiologist
Professor of Radiology (Interventional Radiology) at the Stanford University Medical Center
Contact us to find out if this trial is right for you.
CONTACT
Kamil Unver
(650) 725-9810
View on ClinicalTrials.gov